Global Peripheral Arterial Disease (PAD) Drugs Market Insights and Forecast to 2028

Report ID: 1563653 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Clopidogrel (Plavix)
        1.2.3 Prasugrel (Effient)
        1.2.4 Ticagrelor (Brilinta)
        1.2.5 Vorapaxar (Zontivity)
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Peripheral Arterial Disease (PAD) Drugs Market Perspective (2017-2028)
    2.2 Peripheral Arterial Disease (PAD) Drugs Growth Trends by Region
        2.2.1 Peripheral Arterial Disease (PAD) Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Peripheral Arterial Disease (PAD) Drugs Market Dynamics
        2.3.1 Peripheral Arterial Disease (PAD) Drugs Industry Trends
        2.3.2 Peripheral Arterial Disease (PAD) Drugs Market Drivers
        2.3.3 Peripheral Arterial Disease (PAD) Drugs Market Challenges
        2.3.4 Peripheral Arterial Disease (PAD) Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue
        3.1.1 Global Top Peripheral Arterial Disease (PAD) Drugs Players by Revenue (2017-2022)
        3.1.2 Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Peripheral Arterial Disease (PAD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Peripheral Arterial Disease (PAD) Drugs Revenue
    3.4 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio
        3.4.1 Global Peripheral Arterial Disease (PAD) Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Peripheral Arterial Disease (PAD) Drugs Revenue in 2021
    3.5 Peripheral Arterial Disease (PAD) Drugs Key Players Head office and Area Served
    3.6 Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service
    3.7 Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Peripheral Arterial Disease (PAD) Drugs Breakdown Data by Type
    4.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2023-2028)
5 Peripheral Arterial Disease (PAD) Drugs Breakdown Data by Application
    5.1 Global Peripheral Arterial Disease (PAD) Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size (2017-2028)
    6.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type
        6.2.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022)
        6.2.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028)
        6.2.3 North America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2017-2028)
    6.3 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application
        6.3.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022)
        6.3.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028)
        6.3.3 North America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2017-2028)
    6.4 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country
        6.4.1 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2017-2022)
        6.4.2 North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size (2017-2028)
    7.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type
        7.2.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022)
        7.2.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028)
        7.2.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2017-2028)
    7.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application
        7.3.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022)
        7.3.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028)
        7.3.3 Europe Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2017-2028)
    7.4 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country
        7.4.1 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2017-2022)
        7.4.2 Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type
        8.2.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2017-2028)
    8.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application
        8.3.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2017-2028)
    8.4 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region
        8.4.1 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size (2017-2028)
    9.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type
        9.2.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022)
        9.2.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028)
        9.2.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2017-2028)
    9.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application
        9.3.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022)
        9.3.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028)
        9.3.3 Latin America Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2017-2028)
    9.4 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country
        9.4.1 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2017-2022)
        9.4.2 Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type
        10.2.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Type (2017-2028)
    10.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application
        10.3.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Share by Application (2017-2028)
    10.4 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country
        10.4.1 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 AstraZeneca (UK)
        11.1.1 AstraZeneca (UK) Company Details
        11.1.2 AstraZeneca (UK) Business Overview
        11.1.3 AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Introduction
        11.1.4 AstraZeneca (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
        11.1.5 AstraZeneca (UK) Recent Developments
    11.2 Bayer HealthCare Pharmaceuticals (Germany)
        11.2.1 Bayer HealthCare Pharmaceuticals (Germany) Company Details
        11.2.2 Bayer HealthCare Pharmaceuticals (Germany) Business Overview
        11.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Introduction
        11.2.4 Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
        11.2.5 Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
    11.3 Bristol-Myers Squibb Company (US)
        11.3.1 Bristol-Myers Squibb Company (US) Company Details
        11.3.2 Bristol-Myers Squibb Company (US) Business Overview
        11.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Introduction
        11.3.4 Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
        11.3.5 Bristol-Myers Squibb Company (US) Recent Developments
    11.4 Merck & Co (US)
        11.4.1 Merck & Co (US) Company Details
        11.4.2 Merck & Co (US) Business Overview
        11.4.3 Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Introduction
        11.4.4 Merck & Co (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
        11.4.5 Merck & Co (US) Recent Developments
    11.5 Proteon Therapeutics (US)
        11.5.1 Proteon Therapeutics (US) Company Details
        11.5.2 Proteon Therapeutics (US) Business Overview
        11.5.3 Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Introduction
        11.5.4 Proteon Therapeutics (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
        11.5.5 Proteon Therapeutics (US) Recent Developments
    11.6 Sanofi (France)
        11.6.1 Sanofi (France) Company Details
        11.6.2 Sanofi (France) Business Overview
        11.6.3 Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Introduction
        11.6.4 Sanofi (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
        11.6.5 Sanofi (France) Recent Developments
    11.7 Symic Bio (US)
        11.7.1 Symic Bio (US) Company Details
        11.7.2 Symic Bio (US) Business Overview
        11.7.3 Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Introduction
        11.7.4 Symic Bio (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
        11.7.5 Symic Bio (US) Recent Developments
    11.8 TheraVasc (US)
        11.8.1 TheraVasc (US) Company Details
        11.8.2 TheraVasc (US) Business Overview
        11.8.3 TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Introduction
        11.8.4 TheraVasc (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
        11.8.5 TheraVasc (US) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Clopidogrel (Plavix)
    Table 3. Key Players of Prasugrel (Effient)
    Table 4. Key Players of Ticagrelor (Brilinta)
    Table 5. Key Players of Vorapaxar (Zontivity)
    Table 6. Key Players of Others
    Table 7. Global Peripheral Arterial Disease (PAD) Drugs Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Region (2017-2022)
    Table 11. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Region (2023-2028)
    Table 13. Peripheral Arterial Disease (PAD) Drugs Market Trends
    Table 14. Peripheral Arterial Disease (PAD) Drugs Market Drivers
    Table 15. Peripheral Arterial Disease (PAD) Drugs Market Challenges
    Table 16. Peripheral Arterial Disease (PAD) Drugs Market Restraints
    Table 17. Global Peripheral Arterial Disease (PAD) Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Players (2017-2022)
    Table 19. Global Top Peripheral Arterial Disease (PAD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2021)
    Table 20. Ranking of Global Top Peripheral Arterial Disease (PAD) Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Peripheral Arterial Disease (PAD) Drugs Product Solution and Service
    Table 24. Date of Enter into Peripheral Arterial Disease (PAD) Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Peripheral Arterial Disease (PAD) Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Application (2017-2022)
    Table 32. Global Peripheral Arterial Disease (PAD) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Peripheral Arterial Disease (PAD) Drugs Revenue Share by Application (2023-2028)
    Table 34. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 64. AstraZeneca (UK) Company Details
    Table 65. AstraZeneca (UK) Business Overview
    Table 66. AstraZeneca (UK) Peripheral Arterial Disease (PAD) Drugs Product
    Table 67. AstraZeneca (UK) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022) & (US$ Million)
    Table 68. AstraZeneca (UK) Recent Developments
    Table 69. Bayer HealthCare Pharmaceuticals (Germany) Company Details
    Table 70. Bayer HealthCare Pharmaceuticals (Germany) Business Overview
    Table 71. Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Drugs Product
    Table 72. Bayer HealthCare Pharmaceuticals (Germany) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022) & (US$ Million)
    Table 73. Bayer HealthCare Pharmaceuticals (Germany) Recent Developments
    Table 74. Bristol-Myers Squibb Company (US) Company Details
    Table 75. Bristol-Myers Squibb Company (US) Business Overview
    Table 76. Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Drugs Product
    Table 77. Bristol-Myers Squibb Company (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022) & (US$ Million)
    Table 78. Bristol-Myers Squibb Company (US) Recent Developments
    Table 79. Merck & Co (US) Company Details
    Table 80. Merck & Co (US) Business Overview
    Table 81. Merck & Co (US) Peripheral Arterial Disease (PAD) Drugs Product
    Table 82. Merck & Co (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022) & (US$ Million)
    Table 83. Merck & Co (US) Recent Developments
    Table 84. Proteon Therapeutics (US) Company Details
    Table 85. Proteon Therapeutics (US) Business Overview
    Table 86. Proteon Therapeutics (US) Peripheral Arterial Disease (PAD) Drugs Product
    Table 87. Proteon Therapeutics (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022) & (US$ Million)
    Table 88. Proteon Therapeutics (US) Recent Developments
    Table 89. Sanofi (France) Company Details
    Table 90. Sanofi (France) Business Overview
    Table 91. Sanofi (France) Peripheral Arterial Disease (PAD) Drugs Product
    Table 92. Sanofi (France) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022) & (US$ Million)
    Table 93. Sanofi (France) Recent Developments
    Table 94. Symic Bio (US) Company Details
    Table 95. Symic Bio (US) Business Overview
    Table 96. Symic Bio (US) Peripheral Arterial Disease (PAD) Drugs Product
    Table 97. Symic Bio (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022) & (US$ Million)
    Table 98. Symic Bio (US) Recent Developments
    Table 99. TheraVasc (US) Company Details
    Table 100. TheraVasc (US) Business Overview
    Table 101. TheraVasc (US) Peripheral Arterial Disease (PAD) Drugs Product
    Table 102. TheraVasc (US) Revenue in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022) & (US$ Million)
    Table 103. TheraVasc (US) Recent Developments
    Table 104. Research Programs/Design for This Report
    Table 105. Key Data Information from Secondary Sources
    Table 106. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Clopidogrel (Plavix) Features
    Figure 3. Prasugrel (Effient) Features
    Figure 4. Ticagrelor (Brilinta) Features
    Figure 5. Vorapaxar (Zontivity) Features
    Figure 6. Others Features
    Figure 7. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Application: 2021 VS 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. Others Case Studies
    Figure 11. Peripheral Arterial Disease (PAD) Drugs Report Years Considered
    Figure 12. Global Peripheral Arterial Disease (PAD) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Peripheral Arterial Disease (PAD) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Region: 2021 VS 2028
    Figure 15. Global Peripheral Arterial Disease (PAD) Drugs Market Share by Players in 2021
    Figure 16. Global Top Peripheral Arterial Disease (PAD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peripheral Arterial Disease (PAD) Drugs as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Peripheral Arterial Disease (PAD) Drugs Revenue in 2021
    Figure 18. North America Peripheral Arterial Disease (PAD) Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Type (2017-2028)
    Figure 20. North America Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Application (2017-2028)
    Figure 21. North America Peripheral Arterial Disease (PAD) Drugs Market Size Share by Country (2017-2028)
    Figure 22. United States Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Peripheral Arterial Disease (PAD) Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Peripheral Arterial Disease (PAD) Drugs Market Size Share by Country (2017-2028)
    Figure 28. Germany Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Peripheral Arterial Disease (PAD) Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Peripheral Arterial Disease (PAD) Drugs Market Size Share by Region (2017-2028)
    Figure 38. China Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Peripheral Arterial Disease (PAD) Drugs Market Size Share by Country (2017-2028)
    Figure 48. Mexico Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Peripheral Arterial Disease (PAD) Drugs Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Peripheral Arterial Disease (PAD) Drugs Market Size Share by Country (2017-2028)
    Figure 54. Turkey Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Peripheral Arterial Disease (PAD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. AstraZeneca (UK) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
    Figure 58. Bayer HealthCare Pharmaceuticals (Germany) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
    Figure 59. Bristol-Myers Squibb Company (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
    Figure 60. Merck & Co (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
    Figure 61. Proteon Therapeutics (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
    Figure 62. Sanofi (France) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
    Figure 63. Symic Bio (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
    Figure 64. TheraVasc (US) Revenue Growth Rate in Peripheral Arterial Disease (PAD) Drugs Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AstraZeneca (UK)
Bayer HealthCare Pharmaceuticals (Germany)
Bristol-Myers Squibb Company (US)
Merck & Co (US)
Proteon Therapeutics (US)
Sanofi (France)
Symic Bio (US)
TheraVasc (US)
Frequently Asked Questions
Peripheral Arterial Disease (PAD) Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Peripheral Arterial Disease (PAD) Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Peripheral Arterial Disease (PAD) Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports